Today: 14 May 2026

Rivian stock slips again in premarket after CEO share-sale disclosure, with Tesla deliveries next

Rivian stock slips again in premarket after CEO share-sale disclosure, with Tesla deliveries next

Rivian shares fell 0.9% to $19.42 in premarket trading Wednesday after a 5.2% drop the previous session. CEO R.J. Scaringe sold 17,450 shares on Dec. 23 under a pre-arranged plan, according to a regulatory filing. Investors are awaiting Rivian’s quarterly production and delivery update and Tesla’s delivery report for signs of electric-vehicle demand.
31 December 2025
···
XPeng stock today: XPEV slides in premarket as China trade-in subsidies and new G7 REEV grab attention

XPeng stock today: XPEV slides in premarket as China trade-in subsidies and new G7 REEV grab attention

XPeng shares dropped 4.2% to $20.38 in premarket trading Wednesday, reversing a 3.8% gain from the previous session. The move followed China’s announcement of 62.5 billion yuan in 2026 trade-in subsidies for consumer goods, including new-energy vehicles. CEO He Xiaopeng detailed plans for a range-extended G7 model set to debut in early 2026.
31 December 2025
····
TSMC stock today: Taiwan Semi slips premarket on Nvidia H200 supply talks and a 2nm production update

TSMC stock today: Taiwan Semi slips premarket on Nvidia H200 supply talks and a 2nm production update

TSMC’s U.S.-listed shares fell 0.4% to $299.58 in premarket trading after Reuters reported Nvidia asked the chipmaker to expand H200 AI chip production for Chinese buyers. Chinese firms have ordered over 2 million H200 chips for 2026, with pricing near $27,000 each. TSMC also said it began volume production of its 2nm chips in Q4.
31 December 2025
····
Hims & Hers stock dips in premarket as GLP-1 drug pricing pressure stays in focus

Hims & Hers stock dips in premarket as GLP-1 drug pricing pressure stays in focus

Hims & Hers Health shares fell 0.5% to $32.87 in premarket trading Wednesday after closing down 3.1% the previous session. The move follows price cuts by Novo Nordisk and Eli Lilly on obesity drugs in China, raising questions about future margins and demand for GLP-1 therapies. Hims recently launched its weight-loss membership in the UK, offering access to Wegovy and Mounjaro.
31 December 2025
····
Why Oriental Culture Holding OCG stock is moving again in premarket after a 23% jump

Why Oriental Culture Holding OCG stock is moving again in premarket after a 23% jump

Oriental Culture Holding shares rose 1.8% to $0.104 in premarket trading Wednesday after a 23% jump Tuesday, with 342 million shares traded. The company disclosed recent share sales under a $200 million at-the-market program and shareholder approval for a possible reverse split. Traders are watching dilution risk and compliance steps as the stock’s 52-week range spans $0.07 to $19.29.
31 December 2025
·
iSpecimen (ISPC) stock drops in premarket after $5.5 million convertible preferred financing

iSpecimen (ISPC) stock drops in premarket after $5.5 million convertible preferred financing

iSpecimen Inc shares fell about 15% to $0.30 premarket after announcing a $5.5 million private placement of Series C convertible preferred stock. The preferred converts to common shares at a 15% discount to the prior day’s close, raising dilution concerns. The company remains below Nasdaq’s $1 minimum bid, with a compliance deadline of May 2026. Financing is expected to close Wednesday.
31 December 2025
·
Direct Digital (DRCT) stock jumps in premarket as SEC filing spotlights Nasdaq listing crunch

Direct Digital (DRCT) stock jumps in premarket as SEC filing spotlights Nasdaq listing crunch

Direct Digital Holdings shares jumped about 35% in premarket trading after the company disclosed its special shareholder meeting was adjourned for lack of quorum and rescheduled to Dec. 30. Investors are watching a pending vote on a reverse stock split and share-issuance proposals needed to meet Nasdaq’s $1 minimum bid requirement. The company faces a Jan. 30, 2026 deadline to regain compliance or risk delisting.
31 December 2025
··
Ekso Bionics (EKSO) stock slips premarket after ChronoScale AI deal-fueled surge

Ekso Bionics (EKSO) stock slips premarket after ChronoScale AI deal-fueled surge

Ekso Bionics shares fell 8.3% to $9.70 premarket after surging 93.8% Tuesday, following Applied Digital’s plan to merge its cloud unit with Ekso to form ChronoScale. The companies signed a non-binding term sheet, with Applied Digital set to own about 97% of the combined firm. Investors await binding terms, financing details, and SEC filings ahead of a shareholder vote.
31 December 2025
···
Oriental Rise (ORIS) stock jumps premarket after Daguan Tea acquisition LOI

Oriental Rise (ORIS) stock jumps premarket after Daguan Tea acquisition LOI

Oriental Rise Holdings shares rose 36.9% to $1.67 in premarket trading after announcing a non-binding letter of intent to acquire a controlling stake in Hubei Daguan Tea Industry Group. The company did not disclose financial terms and said due diligence is pending. The move follows a 1-for-20 reverse stock split effective Dec. 30. Investors await further details on the deal’s terms, financing, and timeline.
31 December 2025
AFJK jolts higher in premarket as Aimei Health extends a wild run into year-end

AFJK jolts higher in premarket as Aimei Health extends a wild run into year-end

Aimei Health Technology shares jumped 38% to $114 in premarket trading Wednesday, after closing up 89% at $82.58 Tuesday. The surge follows a sharp reduction in outstanding shares after nearly 4 million were redeemed this month, leaving about 2.18 million shares. Trading volume Tuesday was four times the recent average. The company faces a Jan. 6, 2026, deadline to complete its merger with United Hydrogen Group.
31 December 2025
·
Profusa stock whipsaws: PFSA dips premarket after 78% surge on debt restructuring

Profusa stock whipsaws: PFSA dips premarket after 78% surge on debt restructuring

Profusa shares fell about 12% to 10.7 cents in premarket trading Wednesday after a 78% surge the previous day. The company raised the conversion floor on its senior secured convertible notes to $0.35 and eliminated mandatory amortization payments. A filing outlined conditions for up to $5 million in new note financing and referenced a possible reverse stock split in January 2026.
31 December 2025
·
Vanda Pharma stock jumps premarket after FDA approves Nereus, first new motion-sickness vomiting drug in decades

Vanda Pharma stock jumps premarket after FDA approves Nereus, first new motion-sickness vomiting drug in decades

Vanda Pharmaceuticals shares rose about 18% in premarket trading after the FDA approved its motion-sickness drug Nereus (tradipitant). The company plans to launch the oral treatment in the coming months. The approval followed late-stage trials involving 681 patients. Shares closed at $7.03 Tuesday and were indicated around $8.30 early Wednesday.
31 December 2025
···
1 … 944 945 946 947 948 … 1,932

Stock Market Today

  • NVIDIA Stock Rises 2.29% with Strong Technical Indicators but Volume Divergence Signals Caution
    May 13, 2026, 10:42 PM EDT. NVIDIA's stock price increased 2.29% on May 13, 2026, continuing a six-day winning streak and rising 7.92% over two weeks. Notably, the stock broke a strong short-term trend line at $223.03, suggesting further gains toward the $264.30 resistance level. Moving averages signal a buy, with the short-term trend above the long-term. However, declining volume despite rising prices may indicate a potential reversal. Support levels are identified at $213.87, $195.72, and $184.89, with sell signals triggered if these break. Technical caution is advised due to a sell signal from the 3-month MACD indicator and volume-price divergence. Market watchers should monitor NVIDIA closely for short-term shifts amid medium risk trading conditions.

Latest articles

Enovix Stock Drops After Q1 Beat as Smartphone Battery Tests Stay Unfinished

Enovix Stock Drops After Q1 Beat as Smartphone Battery Tests Stay Unfinished

14 May 2026
Enovix shares dropped 12.9% to $6.35 after hours Wednesday despite beating first-quarter revenue and adjusted-loss estimates. The decline followed news that smartphone battery qualification remains unfinished, with the company passing 72 of 75 customer tests. Revenue rose 49% to $7.6 million. Enovix cited progress in defense, industrial, and smart-eyewear sales.
Lightwave Logic Stock Jumps as AI-Photonics Bet Heads for a 2027 Production Test

Lightwave Logic Stock Jumps as AI-Photonics Bet Heads for a 2027 Production Test

14 May 2026
Lightwave Logic reported Q1 revenue up 27% to $29,000 and a net loss widening to $6.3 million. Shares rose 14% after the company said it is negotiating a supply and licensing deal for high-volume production in 2027. Four Fortune 500 customers are now in Stage 3 prototyping. Cash and equivalents totaled about $100 million as of May 11.
USA Rare Earth Stock Watch: Q1 Revenue, $1.75 Billion Cash and the China Supply Crunch

USA Rare Earth Stock Watch: Q1 Revenue, $1.75 Billion Cash and the China Supply Crunch

14 May 2026
USA Rare Earth reported Q1 revenue of $5.7 million and a net loss of $67 million, ending March with $1.75 billion in cash after a $1.5 billion PIPE. The company expects to sign documents this month for $1.6 billion in U.S. Commerce Department funding. Texas awarded a $14.18 million grant for the Round Top project. USA Rare Earth agreed in April to acquire Brazil’s Serra Verde for $2.8 billion.
Go toTop